Welcome to Novo Nordisk in the United States


Partnering for R&D and commercial innovation

Novo Nordisk is focused exclusively on protein-based and peptide-based therapeutics for chronic illnesses. Globally, the company explores partnerships of diverse scope to support its mission of sustainable innovation. Within the United States, Novo Nordisk focuses on strategic partnerships to commercialize innovative therapies for better patient care.

0512-00009435-1 June 2012